ARM unites the cell and gene therapy ecosystem to modernize healthcare systems, overcome obstacles to innovation, and improve patient access to life-changing treatments.

The State of the Industry Briefing is ARM’s annual update on the progress of the cell and gene therapy sector. The event features noteworthy sessions with top executives highlighting future inflection …

Explore how ARM members get involved through forums, advisory groups, and initiatives that shape the future of CGT. Click here to learn more.

From June 12th-13th, 2025, the Alliance for Regenerative Medicine (ARM) and the Cell and Gene Therapy Catapult hosted a 2-day workshop in Stevenage, UK, to explore the use of advanced …

Discover ARM’s A-Cell resource, an extensive case study applying Quality by Design principles to cell therapy CMC program development. Click here.

Join the Alliance for Regenerative Medicine (ARM) in Washington, DC for our upcoming Workshop, where industry leaders, regulators, clinicians and patient advocates will gather to explore the next …

Learn how ARM advances cell and gene therapy manufacturing by promoting best practices, hosting workshops, and publishing whitepapers. Click here.

The event also provides sessions with policy insiders and patient advocates. Join us for two action-packed days of advocating for life-changing cell and gene therapies. Please note that registration is …

The Alliance for Regenerative Medicine (ARM) is pleased to submit comments to the US Food and Drug Administration (FDA) in response to recently released guidance titled, Clinical Trial Considerations to …

Attracting nearly 2,000 attendees both in-person and streaming live, this gathering of key stakeholders in the field includes ARM’s annual update on the sector’s progress and two noteworthy sessions …